ReviewBiomedicines2025

Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction.

Nóra Homoródi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.